Gene expression levels of MLL-AF9 patient blasts as compared with CD34+ cells, monocytes and AML blasts. (a) Distance-based clustering on the expression of all hg19 refSeq genes. (b) PC analysis on the expression of MLL-AF9 target genes. (c) Pathway enrichments for MLL-AF9 target genes in PC1 (top left) and PC2 (top right). Expression levels of MLL-AF9 target genes in PC1 (bottom left) and PC2 (bottom right). (d) Distribution of differentially expressed AP2, C2H2-Zf, ETS, NR, POU and T-box TFs. Green dots: Benjamini–Hochberg-adjusted P-value<0.01 and fold change >4; orange dots: Benjamini–Hochberg-adjusted P-value<0.05; red dots: fold change >1. (e) Euclidean distance clustering of 74 TFs expressed significantly different in MLL-AF9 cells versus monocytes, CD34+ and MLL-AF4 cells. (f and g) Mean RPKM of MLL-AF9 AML high (f) and low (g) expressed TFs in CD34+ cells (n=3), THP-1 (n=2), MV4-11 (n=1), monocytes (n=3), MLL-AF9 blasts (n=5), AML-ETO blasts (CGA, n=7), CBFß-MYH11 blasts (CGA, n=11), MLLr blasts (CGA, n=11), PML-RAR blasts (CGA, n=16) and other AMLs (CGA, n=134).